TGFB1 and non-Hodgkin lymphoma: Using an immunoblastic SAIDS-NHL cell line shown to represent the original tumor mass (Figure 1), initial studies confirmed a previous report [20] that SAIDS-NHL cells may be sensitive to TGF-β1-mediated growth inhibition in a dose-dependent manner (Figure 2A).